The transaction would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira.
Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal
The transaction would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira.